theophylline has been researched along with Hyperlipoproteinemia Type II in 2 studies
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haacke, H | 2 |
Parwaresch, MR | 2 |
Mäder, C | 2 |
Fears, R | 1 |
Ferres, H | 1 |
1 trial available for theophylline and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Cli | 1988 |
1 other study available for theophylline and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
Topics: Adolescent; Adult; Aged; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteine | 1980 |